| Oncology - Extracellular vesicles play key role in cancer drug resistance |
|
|
|
|
| |
|
|
| |
The latest oncology news from News Medical |
|
|
|
 | | |
 Assess Biospecimens for ADC Development with Ki67 Tissue Staining
One of the key markers for ensuring high-quality tumor biospecimens for antibody-drug conjugate (ADC) development is Ki67. Ki67 staining is indispensable for validating tissue blocks, offering essential insights into cell proliferation, tumor heterogeneity, target validation, biomarker correlation, therapeutic efficacy, quality control, and standardization.
| |
|
|
|
|
| | |  A pioneering research study announced today (October 23) will trial multiple new treatments for people in the UK living with glioblastoma, an aggressive form of brain cancer. | | | | |  A study of patients with metastatic lung cancer by researchers based in Brazil and the United States has found that their performance in simple physical tests such as sitting down, standing and walking can help physicians arrive at a prognosis and approach to treatment. | | | | |  Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted therapy extended overall survival (OS) in patients with anaplastic thyroid carcinoma (ATC). Findings from the Phase II single center study published today in JAMA Oncology. | | | | |  Magnetic resonance imaging (MRI) can spare many patients with rectal cancer from invasive surgery that can carry lifelong side effects, new research indicates. | | | | |  The research project Federated Secure Computing, funded by the Stifterverband, handles cancer patient data analysis in the European health data space across national borders without sharing any actual data, utilizing the modern cryptographic method - secure multiparty computation. | |
|
|
|
|
| | | How would you rate today's newsletter?
| |
|
|
|
 | | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
